News and Events - Read more here

HALIX attends 2015 BIO International Convention (June 15-18 in Philadelphia)

03/18/2015

LEIDEN - The Netherlands (18-03-2015): HALIX attends 2015 BIO International Convention (June 15-18 in Philadelphia).

In 2015 the BIO International Convention is headed to the heart of the U.S. biopharma industry. In close proximity to New York's financial markets and Washington, D.C.'s regulatory center, the Philadelphia Metropolitan Area is home to more than 1,200 companies, ranging from the biopharma industry's largest multinational companies to its fastest growing firms. The region's vast array of leading universities and research institutions fosters a collaborative environment. In the past 10 years alone, the region has drawn nearly $4 billion in venture capital funding (according to the Jones Lang LaSalle Life Sciences Cluster Report 2012).

Read more here

About HAL Allergy

HAL Allergy Group is active in the field of biopharmaceuticals and is located at the Bio Science Park in Leiden, The Netherlands. Our core business is the development and manufacturing of therapies and diagnostics for allergic diseases. In addition, we offer contract manufacturing services focusing on the production of biopharmaceutical products for (pre-) clinical studies. With offices in major European countries, HAL Allergy is one of the European top players in the allergy immunotherapy business. Established in 1959 HAL Allergy has long experience in developing, producing and selling allergy therapies with an immuno-modulatory effect causing a reduction in symptoms and long-term disease suppression. The allergy therapies are used against common allergies such as hay fever, house dust mites allergy and allergic reactions towards wasp or bee stings. More information is available on: http://www.hal-allergy.com.   

The main shareholder of HAL Allergy GmbH is Droege International Group AG, which is an independent Advisory and Investment Company, based in Düsseldorf, Germany. More information is available on: http://www.droege-group.com. 

Contact
HAL Allergy Group

Monique Lutgens
Manager Corporate Communications
Tel. + 31 (0)88 1959010
Email: corporatecommunications@hal-allergy.com